Innovative Licensing and Access Pathway
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Read the news from Medicines and Healthcare products Regulatory Agency updated on 5 October 2021.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (14 mars 2022). Innovative Licensing and Access Pathway. ELSIBI. Consulté le 18 mars 2025 à l’adresse https://doi.org/10.58079/o5uy